179 related articles for article (PubMed ID: 26003033)
41. Vertebral fracture in a 7-year-old boy with indolent systemic mastocytosis.
Bocca-Tjeertes IFA; Boot AM; Brand HK; van Doormaal JJ; Oude Elberink HNG
J Allergy Clin Immunol Pract; 2023 Oct; 11(10):3269-3271. PubMed ID: 37399946
[No Abstract] [Full Text] [Related]
42. Gastrointestinal Disease in Mastocytosis.
Hamilton MJ
Immunol Allergy Clin North Am; 2023 Nov; 43(4):711-722. PubMed ID: 37758408
[TBL] [Abstract][Full Text] [Related]
43. Anesthetic considerations in a laboring woman with systemic mastocytosis.
Fernandes AL; Mendonça M; Costa D; Freitas SC; Pereira S
Rev Esp Anestesiol Reanim (Engl Ed); 2021 Jun; ():. PubMed ID: 34154823
[TBL] [Abstract][Full Text] [Related]
44. Clinical spectrum of patients diagnosed with childhood mastocytosis: a retrospective single center experience.
Durmaz AM; Özdemir Ö
Eur Ann Allergy Clin Immunol; 2024 Jun; ():. PubMed ID: 38913387
[No Abstract] [Full Text] [Related]
45. A rare case of well-differentiated systemic mastocytosis.
Patel N; Maric I
Blood; 2023 May; 141(19):2403. PubMed ID: 37166923
[No Abstract] [Full Text] [Related]
46. The Pivotal Role of Whole Genome and Transcriptome Sequencing in a Rare Case of Systemic Mastocytosis with Associated Myelodysplastic/Myeloproliferative Neoplasm with Neutrophilia.
Strasser B; Hörmann G; Haushofer A
Clin Chem; 2024 Jan; 70(1):350-352. PubMed ID: 38175593
[No Abstract] [Full Text] [Related]
47. Safety of a mRNA COVID-19 Vaccine in Patients with Indolent Systemic Mastocytosis.
Gouveia J; Rodrigues MA; Fernandes I; Cabral R; Falcão H
Acta Med Port; 2024 Mar; 37(3):224-225. PubMed ID: 38430469
[No Abstract] [Full Text] [Related]
48. Systemic mastocytosis: dying or survivin.
Dahlin JS; Nilsson G
Blood; 2024 Mar; 143(11):945-947. PubMed ID: 38483409
[No Abstract] [Full Text] [Related]
49. How "benign" is cutaneous mastocytosis? A Danish registry-based matched cohort study.
Kibsgaard L; Deleuran M; Flohr C; Langan S; Braae Olesen A; Vestergaard C
Int J Womens Dermatol; 2020 Sep; 6(4):294-300. PubMed ID: 33015290
[TBL] [Abstract][Full Text] [Related]
50. A study of the safety and effectiveness of lirentelimab as a treatment for people with indolent systemic mastocytosis.
Br J Dermatol; 2023 Oct; 189(5):e88. PubMed ID: 37879742
[No Abstract] [Full Text] [Related]
51. Intestinal perforation secondary to systemic mastocytosis: Report of an exceptional case.
Carballo-Folgoso L; Cuevas-Pérez J; Blanco-García L; Celada-Sendino M; Castaño-Fernández O
Rev Gastroenterol Mex (Engl Ed); 2023; 88(4):450-452. PubMed ID: 38129248
[No Abstract] [Full Text] [Related]
52. Asymptomatic Systemic Mastocytosis Uncovered During Routine Colonoscopy: A Case Report.
Matmatte AS; Hari Narayanan D; Sia T; Shami S; Fu J; Tan PE; Leung J
Cureus; 2024 May; 16(5):e60286. PubMed ID: 38872692
[TBL] [Abstract][Full Text] [Related]
53. A Vertebral Fracture Unmasking Systemic Mastocytosis in a 29-Year-Old Man.
Nguyen CN; Boggs NA; Maxwell DB; Danielson DT; Hoang TD
AACE Clin Case Rep; 2024; 10(3):113-114. PubMed ID: 38799051
[No Abstract] [Full Text] [Related]
54. Case of Solid Œdema.
Hawthorne CO
Proc R Soc Med; 1916; 9(Sect Study Dis Child):32-3. PubMed ID: 19979463
[No Abstract] [Full Text] [Related]
55. [Vulvar oedema revealing systemic mastocytosis].
Deveza E; Locatelli F; Girardin M; Valmary-Degano S; Daguindau E; Aubin F; Humbert P; Pelletier F
Ann Dermatol Venereol; 2015 Nov; 142(11):685-9. PubMed ID: 26003033
[TBL] [Abstract][Full Text] [Related]
56. Evolution of urticaria pigmentosa into indolent systemic mastocytosis: abnormal immunophenotype of mast cells without evidence of c-kit mutation ASP-816-VAL.
Noack F; Escribano L; Sotlar K; Nunez R; Schuetze K; Valent P; Horny HP
Leuk Lymphoma; 2003 Feb; 44(2):313-9. PubMed ID: 12688351
[TBL] [Abstract][Full Text] [Related]
57. Transglutaminase 2 expressed in mast cells recruited into skin or bone marrow induces the development of pediatric mastocytosis.
Ahn YM; Hong GU; Kim SH; Lee HJ; Baek HS; Kim MN; Park KY; Ro JY
Pediatr Allergy Immunol; 2015 Aug; 26(5):438-45. PubMed ID: 25952500
[TBL] [Abstract][Full Text] [Related]
58. Mast Cell Burden in a Patient With Cutaneous Disease.
Awosika O; Eleryan M; Rengifo-Pardo M; Ehrlich A
J Drugs Dermatol; 2017 Dec; 16(12):1285-1287. PubMed ID: 29240865
[TBL] [Abstract][Full Text] [Related]
59. Mastocytosis: state of the art.
Horny HP; Sotlar K; Valent P
Pathobiology; 2007; 74(2):121-32. PubMed ID: 17587883
[TBL] [Abstract][Full Text] [Related]
60. [Tryptase: A practical guide for the physician].
Lobbes H; Reynaud Q; Mainbourg S; Lega JC; Durieu I; Durupt S
Rev Med Interne; 2020 Nov; 41(11):748-755. PubMed ID: 32712042
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
